APA (7th ed.) Citation

Maksymowych, W. P., Landewe, R., Boers, M., Garnero, P., Geusens, P., El-Gabalawy, H., . . . van der Heijde, D. (2007). Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials. Journal of rheumatology, 34(3), 634.

Chicago Style (17th ed.) Citation

Maksymowych, Walter P., et al. "Development of Draft Validation Criteria for a Soluble Biomarker to Be Regarded as a Valid Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis and Spondyloarthritis Clinical Trials." Journal of Rheumatology 34, no. 3 (2007): 634.

MLA (9th ed.) Citation

Maksymowych, Walter P., et al. "Development of Draft Validation Criteria for a Soluble Biomarker to Be Regarded as a Valid Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis and Spondyloarthritis Clinical Trials." Journal of Rheumatology, vol. 34, no. 3, 2007, p. 634.